ERBB2 and breast carcinoma: Ttnpb is a cancer treatment for HER2-positive breast cancer and is also an effective retinoic acid receptor (RAR) agonist, which has been shown to convert mouse fibroblasts into hair follicle stem cells (DPC-LC) (Ma et al., 2022).